Article
A transgenic mouse model for mammary carcinogenesis.
Oncogene - 26 Feb 1998
Li B, Murphy K L, Laucirica R, Kittrell F, Medina D, Rosen J M
Abstract excerpt
Missense mutations in the p53 tumor suppressor occur frequently in human breast cancer and influence both the prognosis and response to chemotherapy. Amino acid 175 (equivalent to murine 172) is the second most common site of missense mutations in p53 in human breast cancer. Over 95% of these mutations are arginine-to-histidine (R-H) substitutions resulting in a gain-of-function, and not merely a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.